The company had posted a net profit of Rs 196.78 crore for the corresponding period a year ago, GSK said in a BSE filing.
Net sales during the period under review was Rs 1,052.83 crore, down 9.63 per cent from Rs 1,165.06 crore in the corresponding period last fiscal.
For the full fiscal, GSK's standalone net profit rose 17.70 per cent to Rs 686.91 crore as against Rs 583.60 crore in 2014-15.
However, its net sales declined 0.72 per cent to Rs 4,106.61 crore in 2015-16 from Rs 4,136.44 crore a year ago.
Shares of the company today settled 1.20 per cent lower at Rs 6,086.00 per scrip on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%